Cargando…

Vitreoretinal abnormalities in corona virus disease 2019 patients: What we know so far

The coronavirus disease 2019 (COVID-19) has become a global pandemic since December 2019. Although COVID-19 primarily affects the respiratory systems, it has become abundantly clear that it involves multiple organs including the heart, kidney, skin, and brain. Neuro-ophthalmic signs and anterior seg...

Descripción completa

Detalles Bibliográficos
Autores principales: Sutandi, Nathania, Lee, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493986/
https://www.ncbi.nlm.nih.gov/pubmed/34703738
http://dx.doi.org/10.4103/tjo.tjo_30_21
_version_ 1784579225243615232
author Sutandi, Nathania
Lee, Felix
author_facet Sutandi, Nathania
Lee, Felix
author_sort Sutandi, Nathania
collection PubMed
description The coronavirus disease 2019 (COVID-19) has become a global pandemic since December 2019. Although COVID-19 primarily affects the respiratory systems, it has become abundantly clear that it involves multiple organs including the heart, kidney, skin, and brain. Neuro-ophthalmic signs and anterior segment inflammation of the eyes were documented in COVID-19 patients recently. Small but growing number of literatures has also reported the cases of new onset vitreoretinal disorders related to COVID-19 infection. A comprehensive search from four online databases was done. Findings show vitreoretinal involvement in COVID-19 patients including the central retinal vein occlusion, central retinal artery occlusion, reactivation of previous uveitis, chorioretinitis, macular hemorrhage, acute macular neuroretinopathy, paracentral acute middle maculopathy, vitritis with outer retinal abnormalities, varicella zoster virus-related acute retinal necrosis in immunocompromised patient, and other posterior segment pathological changes. The hypotheses for potential pathogenesis of these manifestations are direct viral ocular infection and thromboembolic complications secondary to the hyperinflammatory response. This is the first review article, which provides an overview of current evidence regarding the vitreoretinal manifestations in COVID-19 patients.
format Online
Article
Text
id pubmed-8493986
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-84939862021-10-25 Vitreoretinal abnormalities in corona virus disease 2019 patients: What we know so far Sutandi, Nathania Lee, Felix Taiwan J Ophthalmol Review Article The coronavirus disease 2019 (COVID-19) has become a global pandemic since December 2019. Although COVID-19 primarily affects the respiratory systems, it has become abundantly clear that it involves multiple organs including the heart, kidney, skin, and brain. Neuro-ophthalmic signs and anterior segment inflammation of the eyes were documented in COVID-19 patients recently. Small but growing number of literatures has also reported the cases of new onset vitreoretinal disorders related to COVID-19 infection. A comprehensive search from four online databases was done. Findings show vitreoretinal involvement in COVID-19 patients including the central retinal vein occlusion, central retinal artery occlusion, reactivation of previous uveitis, chorioretinitis, macular hemorrhage, acute macular neuroretinopathy, paracentral acute middle maculopathy, vitritis with outer retinal abnormalities, varicella zoster virus-related acute retinal necrosis in immunocompromised patient, and other posterior segment pathological changes. The hypotheses for potential pathogenesis of these manifestations are direct viral ocular infection and thromboembolic complications secondary to the hyperinflammatory response. This is the first review article, which provides an overview of current evidence regarding the vitreoretinal manifestations in COVID-19 patients. Wolters Kluwer - Medknow 2021-08-28 /pmc/articles/PMC8493986/ /pubmed/34703738 http://dx.doi.org/10.4103/tjo.tjo_30_21 Text en Copyright: © 2021 Taiwan J Ophthalmol https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Review Article
Sutandi, Nathania
Lee, Felix
Vitreoretinal abnormalities in corona virus disease 2019 patients: What we know so far
title Vitreoretinal abnormalities in corona virus disease 2019 patients: What we know so far
title_full Vitreoretinal abnormalities in corona virus disease 2019 patients: What we know so far
title_fullStr Vitreoretinal abnormalities in corona virus disease 2019 patients: What we know so far
title_full_unstemmed Vitreoretinal abnormalities in corona virus disease 2019 patients: What we know so far
title_short Vitreoretinal abnormalities in corona virus disease 2019 patients: What we know so far
title_sort vitreoretinal abnormalities in corona virus disease 2019 patients: what we know so far
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493986/
https://www.ncbi.nlm.nih.gov/pubmed/34703738
http://dx.doi.org/10.4103/tjo.tjo_30_21
work_keys_str_mv AT sutandinathania vitreoretinalabnormalitiesincoronavirusdisease2019patientswhatweknowsofar
AT leefelix vitreoretinalabnormalitiesincoronavirusdisease2019patientswhatweknowsofar